Nano Flow’s Ebola Virus Nucleoprotein (NP) gold conjugate is built on a highly specific monoclonal antibody targeting the nucleoprotein of Ebola Virus (EBOV). Validated as a detection antibody in lateral flow assays, it provides reliable performance for Ebola diagnostics. The corresponding capture antibody is also available, enabling developers to create optimized antibody pairs for rapid and sensitive test development.
Ebola Virus (NP) Gold Conjugate – 40 nm (Ref NF-EBOVNP-AU)

This conjugate reacts with Ebola Virus nucleoproteins of both Sudan and Zaire strains, as well as Ebola Virus-Like Particles (VLPs). Produced on Nano Flow’s highly spherical 40 nm gold nanoparticles (OD20), it ensures reproducibility, long-term stability, and strong visual signal intensity in lateral flow formats and other immunoassays.
Applications: Lateral flow assays (LF) and other immunoassay formats.
Certificate of Analysis: Provided for each batch, including TEM, DLS, and UV-Vis characterization.
Technical Specifications
| Parameter | Specification |
|---|---|
| Antibody format | IgG1, kappa |
| Host | Mouse |
| Clonality | Monoclonal |
| Specificity | Ebola Virus Nucleoprotein (NP) |
| Cross-reactivity | Reacts with Ebola NP of Sudan and Zaire strains, and Ebola Virus-Like Particles (VLPs) |
| Gold nanoparticle size | 40 nm |
| Concentration of the gold conjugate | OD20 |
| Buffer | Borate, BSA 0.25%, NaN₃ 0.09%, pH 7.3 |
| Shelf life | 1 year |
| Available volumes | From 1 ml to 1 L+ |